INFU News and Press, InfuSystems Holdings Inc. From 07/21/25

2025-07-21 20:40:00 ET A look forward Market Commentary Year to date the S&P 500 ( SP500 , SPX ) is up overcoming concerns about the reciprocal tariff regime proposed by President Trump at the beginning of the second quarter. Current economic indicators indicate slow...

2025-06-22 01:30:03 ET InfuSystem ( INFU ) facilitates outpatient care by providing durable medical equipment, infusion pumps, related consumables, and comprehensive biomedical and clinical support services to improve continuity and quality of patient care from healthcare facilities...

2025-05-10 12:06:23 ET InfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call May 08, 2025 09:00 A.M. ET Company Participants Joe Dorame - Managing Partner Richard Dilorio - CEO Barry Steele - EVP and CFO Carrie Lachance - President and COO Conference C...

2025-05-08 06:40:26 ET More on InfuSystem InfuSystem Holdings, Inc. (INFU) Q4 2024 Earnings Call Transcript InfuSystem Set For Strong Year InfuSystem GAAP EPS of $0.04 misses by $0.03, revenue of $33.85M misses by $1.05M Seeking Alpha’s Quant Rating on...

Record Net Revenues of $34.7 million Representing 9% Growth from the Prior Year Net loss of $0.3 million Adjusted EBITDA (non-GAAP) of $6.3 million, up 64% Adjusted EBITDA (non-GAAP) margin expanded by 6.2% to 18.2% Stock Repurchases totaled approxi...

2025-05-02 10:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

Investor Conference Call to be held 9:00 a.m. Eastern Time InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufac...

2025-04-17 03:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

The Company Reaffirms Full Year 2025 Guidance: Revenue Growth of 8-10% and Adjusted EBITDA (non-GAAP) margin greater than 18.8% InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service...

2025-03-04 13:05:16 ET InfuSystem Holdings, Inc. (INFU) Q4 2024 Results Conference Call March 04, 2025 09:00 AM ET Company Participants Joe Dorame - Managing Partner Rich Dilorio - Chief Executive Officer Barry Steele - Chief Financial Officer Carrie Lachance...